Prisma Health | Midlands Clinical Research Unit

Research site

(Unclaimed)

Location

9 Medical Park Drive, Suite 400, Columbia, South Carolina, United States of America

Site insights

Top conditions

Top treatments

L-Arginine

Vitamin D

Astaxanthin

Vitamin C

Iron

Ianalumab

Diuretic

Parent organization

This site is a part of Prisma Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 13 total trials

Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study

Prospective, randomized, open-label, international, multi-center clinical study to evaluate the safety and efficacy of the AccuCinch Ventricular Rest...

Enrolling

Heart Failure with Reduced Ejection Fraction (HFrEF)

Dilated Cardiomyopathy

Device: AccuCinch Ventricular Restoration System

Drug: Guideline-Directed Medical Therapy

Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study (FROST-HF)

The purpose of this clinical study is to assess the safety and effectiveness of the Atrial Flow Regulator in the treatment of subjects, 18 years of a...

Active, not recruiting

Heart Failure With Preserved Ejection Fraction (HFpEF)

Heart Failure With Reduced Ejection Fraction (HFrEF)

Device: Atrial Flow Regulator

Device: Sham Comparator

Fluid Management of Acute Decompensated Heart Failure Subjects Treated with Reprieve Decongestion Management System (DMS) (FASTR)

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve DMS system to Optimal Diuretic Therapy (ODT...

Active, not recruiting

Acute Decompensated Heart Failure

Device: Reprieve Decongestion Management System

Drug: Diuretic

Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)

The trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneou...

Enrolling

Systemic Lupus Erythematosus

Drug: Placebo

Drug: Ianalumab

Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial (DTU-STEMI)

The purpose of this research study is to evaluate whether using the the IMPELLA® CP System temporary circulatory assist device for 30 minutes prior t...

Active, not recruiting

ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

Device: Impella CP® placement prior to reperfusion with Primary PCI

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms